By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Lannett Company, Inc. 

9000 State Road

Philadelphia  Pennsylvania  19136  U.S.A.
Phone: 800-325-9994 Fax: 215-333-9004


SEARCH JOBS


Industry
Suppliers






Company News
Lannett (LCI) Announces Preliminary Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Comments On Fiscal 2018 Outlook 8/8/2017 12:19:36 PM
Lannett (LCI) Appoints Samuel H. Israel As General Counsel 7/17/2017 9:57:49 AM
Lannett (LCI) Receives Approval For Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL 7/14/2017 6:36:20 AM
Lannett (LCI) Receives Approval For Additional Dosage Strengths Of Hydrocodone Bitartrate And Acetaminophen Tablets USP 6/26/2017 7:38:05 AM
Lannett (LCI) Receives Approval For Hydrocodone Bitartrate And Acetaminophen Tablets USP, 5 Mg/300 Mg, 7.5 Mg/300 Mg And 10 Mg/300 Mg 6/22/2017 6:21:23 AM
Lannett (LCI) Names Patrick G. LePore To Board of Directors 6/20/2017 9:38:16 AM
Lannett (LCI) Receives Approval For Niacin Extended-Release Tablets USP, 500 Mg And 1000 Mg 6/19/2017 6:36:31 AM
Lannett (LCI) Announces Approval For Amantadine Hydrochloride Capsules USP, 100 Mg 6/16/2017 6:23:48 AM
Lannett (LCI) Announces Approval For Levocetirizine Dihydrochloride Oral Solution, 2.5 mg/5 mL (0.5 mg/mL) 5/16/2017 9:18:25 AM
Lannett (LCI) Voluntarily Pays Down Remaining $25 Million Principal Balance Of Revolving Credit Facility 5/9/2017 7:45:01 AM
12345678910...
//-->